In recent trading session, Caredx Inc (NASDAQ:CDNA) saw 5.85 million shares changing hands at last check today with its beta currently measuring 2.25. Company’s recent per share price level of $12.26 trading at -$6.94 or -36.17% at last check today assigns it a market valuation of $682.40M. That most recent trading price of CDNA’s stock is at a discount of -184.18% from its 52-week high price of $34.84 and is indicating a discount of -14.93% from its 52-week low price of $14.09. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.87 million shares which gives us an average trading volume of 1.13 million if we extend that period to 3-months.
For Caredx Inc (CDNA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.75. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Caredx Inc (NASDAQ:CDNA) trade information
Upright in the red during last session for losing -36.17%, in the last five days CDNA remained trading in the red while hitting it’s week-highest on Friday, 07/11/25 when the stock touched $12.26 price level, adding 41.06% to its value on the day. Caredx Inc’s shares saw a change of -24.07% in year-to-date performance and have moved -40.59% in past 5-day. Caredx Inc (NASDAQ:CDNA) showed a performance of -35.73% in past 30-days. Number of shares sold short was 6.28 million shares which calculate 5.19 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 25 to the stock, which implies a rise of 50.96% to its recent value today. Analysts have been projecting 25 as a low price target for the stock while placing it at a high target of 25. It follows that stock’s current price would drop -103.92% in reaching the projected high whereas dropping to the targeted low would mean a loss of -103.92% for stock’s current value.
In 2025, company’s earnings growth rate is likely to be around -137.81% while estimates for its earnings growth in next 5 years are of -11.41%.
Caredx Inc (NASDAQ:CDNA)’s Major holders
Insiders are in possession of 3.22% of company’s total shares while institution are holding 99.39 percent of that, with stock having share float percentage of 102.70%. Investors also watch the number of corporate investors in a company very closely, which is 99.39% institutions for Caredx Inc that are currently holding shares of the company. ARK INVESTMENT MANAGEMENT LLC is the top institutional holder at CDNA for having 5.7 million shares of worth $88.56 million. And as of 2024-06-30, it was holding 10.925 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 5.29 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.1283 of outstanding shares, having a total worth of $82.1 million.
On the other hand, ARK ETF Trust-ARK Genomic Revolution ETF and BARON INVESTMENT Fd.S TRT -BARON DISCOVERY Fd. are the top two Mutual Funds which own company’s shares. As of Jun 30, 2025 , the former fund manager was holding 2.05 shares of worth $24.84 million or 3.68% of the total outstanding shares. The later fund manager was in possession of 1.68 shares on Mar 31, 2025 , making its stake of worth around $20.38 million in the company or a holder of 3.02% of company’s stock.
